期刊
DIABETOLOGIA
卷 48, 期 11, 页码 2330-2333出版社
SPRINGER
DOI: 10.1007/s00125-005-1932-y
关键词
adiponectin; insulin resistance; insulin sensitivity; leptin; metabolic syndrome; plasminogen-activator inhibitor 1; resistin
资金
- NCRR NIH HHS [RR-37, RR-16066] Funding Source: Medline
- NHLBI NIH HHS [HL-30086, HL-07028] Funding Source: Medline
- NIDDK NIH HHS [DK-02654, DK-17047, DK-35747, DK-35816] Funding Source: Medline
Aims/hypothesis: The aim of this study was to further elucidate the relationship between resistin and insulin sensitivity, body fat distribution and the metabolic syndrome in humans. Methodds: We measured plasma resistin levels in 177 non-diabetic subjects (75 male, 102 female; age 32-75 years). BMI, waist circumference, blood pressure, lipids, glucose, plasminogen-activator inhibitor 1 (PAI-1), adiponectin and leptin levels were also measured. The insulin sensitivity index (S-I) was quantified using Bergman's minimal model. Intra-abdominal fat (IAF) and subcutaneous fat (SQF) areas were quantified by CT scan. Presence of metabolic syndrome criteria was determined using the National Cholesterol Education Program Adult Treatment Panel III guidelines. Results: When subjects were divided into categories based on BMI (< or >= 27.5 kg/m(2)) and S-I (< or >= 7x10(-5) min(-1) [pmol/l](-1)), resistin levels did not differ between the lean, insulin-sensitive (n=53, 5.36 +/- 0.3 ng/ml), lean, insulin-resistant (n=67, 5.70 +/- 0.4 ng/ml) and obese, insulin-resistant groups (n=48, 5.94 +/- 0.4 ng/ml; ANOVA p=0.65). Resistin correlated with age (r=-0.22, p < 0.01), BMI (r=0.16, p=0.03) and SQF (r=0.19, p=0.01) but not with S-I (p=0.31) or IAF (p=0.52). Resistin did not correlate with the number of metabolic syndrome criteria or any of the individual metabolic syndrome criteria. In contrast, adiponectin, PAI-1 and leptin each correlated with IAF, SQF and S-I. Additionally, the number of metabolic syndrome criteria correlated with adiponectin (r=-0.32, p < 0.001), leptin (r=0.31, p < 0.001) and PAI-1 (r=0.26, p=0.001). Conclusions/interpretation: In contrast to other adipokines, resistin is only weakly associated with body fat and is unlikely to be a major mediator of insulin resistance or the metabolic syndrome in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据